According to research, a combination of drugs was dramatically more effective and less prone to resistance than treatment with a KRAS inhibitor alone for pancreatic cancer.
Research shows novel drug pairing could beat pancreatic cancer medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Mutations in the KRAS gene are the major driver of pancreatic cancer. The resulting protein controls multiple signaling pathways involved in cell growth and survival. In cancer, the gene is mutated to be permanently "on," driving cells to excessively multiply and form tumors.